scispace - formally typeset
S

Sophie Morois

Researcher at South University

Publications -  12
Citations -  1202

Sophie Morois is an academic researcher from South University. The author has contributed to research in topics: European Prospective Investigation into Cancer and Nutrition & Nested case-control study. The author has an hindex of 10, co-authored 12 publications receiving 1113 citations. Previous affiliations of Sophie Morois include French Institute of Health and Medical Research & International Agency for Research on Cancer.

Papers
More filters
Journal ArticleDOI

Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies.

TL;DR: Overall, data from the present study and previous prospective studies combined indicate a relatively modest association of colorectal cancer risk with serum IGF‐I.
Journal ArticleDOI

Mediterranean diet and colorectal cancer risk: results from a European cohort

Christina Bamia, +53 more
TL;DR: It is suggested that following a Mediterranean diet may have a modest beneficial effect on CRC risk, mainly manifested for colon cancer risk and their magnitude was not altered when alcohol was excluded from MMDS.
Journal ArticleDOI

Variety in vegetable and fruit consumption and the risk of gastric and esophageal cancer in the European prospective investigation into cancer and nutrition

TL;DR: Independent from quantity of consumption, more variety in vegetable and fruit consumption combined and in fruit consumption alone may decrease the risk of esophageal squamous cell carcinoma, however, residual confounding by lifestyle factors cannot be excluded.
Journal ArticleDOI

Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.

V. A. Grote, +58 more
- 28 Sep 2011 - 
TL;DR: The data on HbA1c show that individuals who develop exocrine pancreatic cancer tend to have moderate increases in Hb a1c levels, relatively independently of obesity and insulin resistance—the classic and major risk factors for type 2 diabetes.